Full Name | Ashisna Khadka |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 5 Years |
Location | 385 W Main St, Avon, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699342931 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 9690 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hartford Healthcare Urgent Care Centers Llc | 7618242777 | 134 |
News Archive
Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 8 days ago
Entity Name | Stony Creek Urgent Care Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992969364 PECOS PAC ID: 1355498072 Enrollment ID: O20090416000151 |
News Archive
Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 8 days ago
Entity Name | Patient Choice Medical Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558715466 PECOS PAC ID: 7911299128 Enrollment ID: O20160708001044 |
News Archive
Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 8 days ago
Entity Name | Hartford Healthcare Urgent Care Centers Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093239683 PECOS PAC ID: 7618242777 Enrollment ID: O20170929001464 |
News Archive
Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 8 days ago
Entity Name | Healthfair Plus Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376973461 PECOS PAC ID: 2365668720 Enrollment ID: O20220307000909 |
News Archive
Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Ashisna Khadka, 1290 Silas Deane Hwy, Hhc Cvo Enrollment, Wethersfield, CT 06109-4337 Ph: () - | Ashisna Khadka, 385 W Main St, Avon, CT 06001-4357 Ph: (860) 777-1280 |
News Archive
Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 8 days ago
Sasha Perry, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 | |
Deborah L Collins-perrica, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 Fax: 860-284-6804 | |
Latonya Sheriee King, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 152 Simsbury Rd Bldg 9, Avon, CT 06001 Phone: 802-565-1755 Fax: 860-650-1920 | |
Courtney Streeto, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 | |
Marjorie Arni, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691 Fax: 860-677-6443 | |
Mr. David Yarbrough, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 385 W Main St, Avon, CT 06001 Phone: 860-777-1280 | |
Debra Anne Gage, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 80 Fisher Drive, Hartford Hospital Cancer Center, Avon, CT 06001 Phone: 860-674-0088 |